Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results
Thursday, January 31, 2013
UNION CITY, Calif.,
Jan. 23, 2013 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company
manufacturing point-of-care blood analysis systems, has scheduled a
conference call to discuss its financial results for the third
quarter of fiscal year 2013, ended December
31, 2012. The call will be at 4:15
p.m. ET on Thursday, January
31, 2013. The Company will report financial results
for the third quarter of fiscal 2013 after the market closes on
Thursday, January 31, 2013.
Participants can dial (877) 317-6789 or (412) 317-6789 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
Company's website at www.abaxis.com. A replay of the call is
available by visiting www.abaxis.com for the next 30 days or by
calling (877) 344-7529 or (412) 317-0088, confirmation code
10024107, through February 7,
2013.
About Abaxis
Abaxis develops, manufactures, markets
and sells portable blood analysis systems for use in any veterinary
or human patient-care setting to provide clinicians with rapid
blood constituent measurements. The system consists of a
compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series
of single-use plastic discs, called reagent discs that contain all
the chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The
system can be operated with minimal training and performs multiple
routine tests on whole blood, serum or plasma samples. The
system provides test results in less than 12 minutes with the
precision and accuracy equivalent to a clinical laboratory
analyzer. The veterinary business also provides to the animal
health and research market a line of hematology instruments for
point-of-care complete blood counts (CBC), a specialty instrument
to screen for and detect clotting disorders and to measure equine
fibrinogen levels, a handheld instrument for the rapid assessment
of certain critical care tests and rapid point-of-care tests for
Heartworm infections, Parvovirus, Giardia and Lyme disease.
Abaxis, through its AVRL division, provides routine laboratory
testing as well as specialty testing for veterinarians
nationwide.
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief
Executive Officer
|
Joe Dorame, Joe Diaz &
Robert Blum
|
|
Abaxis,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
SOURCE Abaxis, Inc.